Bernard A. Liu

2.1k citations

23 papers · 1.3k indexed · h-index 14

Molecular Biology top 10%
Oncology top 10%
Radiology, Nuclear Medicine and Imaging top 5%
Cell Biology top 10%
Immunology

Co-authors: Piers Nash Tony Pawson Karl Jablonowski Brett W. Engelmann Michael J. Wagner Andrew B. Stergachis Richard B. Jones Kazuya Machida
Topics: Monoclonal and Polyclonal Antibodies Research (8 papers)Protein Kinase Regulation and GTPase Signaling (7 papers)Protein Tyrosine Phosphatases (5 papers)
Cited by: Molecular Biology Immunology and Allergy Radiology, Nuclear Medicine and Imaging
Journals: Proceedings of the National Academy of Sciences Journal of Biological ChemistrySHILAP Revista de lepidopterología
Partner nations: United States Canada Singapore

In The Last Decade

Bernard A. Liu

22 papers receiving 1.3k citations

Peers

Countries citing papers authored by Bernard A. Liu

Since Specialization

Citations

This map shows the geographic impact of Bernard A. Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernard A. Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernard A. Liu more than expected).

Fields of papers citing papers by Bernard A. Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernard A. Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernard A. Liu. The network helps show where Bernard A. Liu may publish in the future.

Co-authorship network of co-authors of Bernard A. Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Bernard A. Liu. A scholar is included among the top collaborators of Bernard A. Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernard A. Liu. Bernard A. Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	1187 Enfortumab vedotin induces immunogenic cell death, elicits antitumor immune memory, and shows enhanced preclinical activity in combination with immune checkpoint inhibitors 2022 ·Regular and Young Investigator Award Abstracts ·(unknown),(unknown),Bernard A. Liu,(unknown),John J. Gosink,(unknown),(unknown),Kelly Hensley,(unknown),Albina Nesterova,(unknown),Anthony Cao,Christine O’Day,Ryan A. Heiser,Timothy S. Lewis,Shyra J. Gardai,(unknown),Masashi Shimazaki,(unknown),Sharsti Sandall	10
2	Abstract 1140: Enfortumab vedotin, a Nectin-4 directed ADC, demonstrates compelling tolerability and anti-tumor activity with intravesical instillation in preclinical models of non-muscle invasive bladder cancer 2022 ·Cancer Research ·(unknown),(unknown),(unknown),Anthony Lee,(unknown),Amit Garg,Christine O’Day,Esther S. Trueblood,Jennifer Wright,Mark Bieda,Charles W. Caldwell,Kelly Hensley,(unknown),Bernard A. Liu,Masashi Shimazaki,Sharsti Sandall	2
3	MCC is a centrosomal protein that relocalizes to non-centrosomal apical sites during intestinal cell differentiation 2022 ·Journal of Cell Science ·(unknown),Bernard A. Liu,(unknown),Sheena L. M. Ong,(unknown),Nicholas S. Tolwinski,Christopher S. Williams,Anne‐Claude Gingras,Marc Leushacke,N. Ray Dunn	0
4	Abstract 5581: Enfortumab vedotin, an anti-Nectin-4 ADC demonstrates bystander cell killing and immunogenic cell death anti-tumor activity mechanisms of action in urothelial cancers 2020 ·Cancer Research ·Bernard A. Liu,(unknown),(unknown),John J. Gosink,(unknown),(unknown),Anthony Cao,(unknown),Albina Nesterova,Kelly Hensley,Julia H. Cochran,Shyra J. Gardai,Timothy S. Lewis	24
5	618 Vedotin ADCs induce ER stress and elicit hallmarks of ICD across multiple cancer indications 2020 ·SHILAP Revista de lepidopterología ·Kerry Klussman,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Anthony Cao,Shyra J. Gardai,Bernard A. Liu	5
6	Abstract 5619: Additional mechanisms of action of SGN-CD48A in multiple myeloma and improved antitumor activity in combination with daratumumab 2018 ·Cancer Research ·(unknown),Bernard A. Liu,(unknown),Anthony Cao,Jesse L. Gurgel,Julia H. Cochran,Nicole Stevens,Martha E. Anderson,Timothy S. Lewis	4
7	Binding Assays Using Recombinant SH2 Domains: Far-Western, Pull-Down, and Fluorescence Polarization 2017 ·Methods in molecular biology ·Kazuya Machida,Bernard A. Liu	4
8	Expression and Production of SH2 Domain Proteins 2017 ·Methods in molecular biology ·Bernard A. Liu,Mari Ogiue‐Ikeda,Kazuya Machida	5
9	Characterizing SH2 Domain Specificity and Network Interactions Using SPOT Peptide Arrays 2017 ·Methods in molecular biology ·Bernard A. Liu	4
10	SH2 Domains 2017 ·Methods in molecular biology ·Kazuya Machida,Bernard A. Liu	1
11	Selection of recombinant anti‐SH3 domain antibodies by high‐throughput phage display 2015 ·Protein Science ·Haiming Huang,(unknown),Bernard A. Liu,Andrea C. Uetrecht,(unknown),Nick Jarvik,Vincent Nadeem,Tony Pawson,Jason Moffat,Shane Miersch,Sachdev S. Sidhu	14
12	Molecular Mechanisms of SH2- and PTB-Domain-Containing Proteins in Receptor Tyrosine Kinase Signaling 2013 ·Cold Spring Harbor Perspectives in Biology ·Michael J. Wagner,(unknown),Bernard A. Liu,Tony Pawson	114
13	SRC Homology 2 Domain Binding Sites in Insulin, IGF-1 and FGF receptor mediated signaling networks reveal an extensive potential interactome 2012 ·Cell Communication and Signaling ·Bernard A. Liu,Brett W. Engelmann,Karl Jablonowski,(unknown),Andrew B. Stergachis,Piers Nash	33
14	High‐throughput analysis of peptide‐binding modules 2012 ·PROTEOMICS ·Bernard A. Liu,Brett W. Engelmann,Piers Nash	40
15	The language of SH2 domain interactions defines phosphotyrosine‐mediated signal transduction 2012 ·FEBS Letters ·Bernard A. Liu,Brett W. Engelmann,Piers Nash	92
16	The Bcl-2/Bcl-XL/Bcl-w Inhibitor, Navitoclax, Enhances the Activity of Chemotherapeutic Agents In Vitro and In Vivo 2011 ·Molecular Cancer Therapeutics ·Jun Chen,Sha Jin,(unknown),Xiaoli Huang,Bernard A. Liu,Michael J. Mitten,Paul Nimmer,Xiaoyu Lin,Morey L. Smith,Yu Shen,Alexander R. Shoemaker,Stephen K. Tahir,Haichao Zhang,Scott Ackler,Saul H. Rosenberg,Heather Maecker,Deepak Sampath,Joel Johansson,Chris Tse,Steven W. Elmore	119
17	SH2 Domains Recognize Contextual Peptide Sequence Information to Determine Selectivity 2010 ·Molecular & Cellular Proteomics ·Bernard A. Liu,Karl Jablonowski,(unknown),Brett W. Engelmann,Richard B. Jones,Piers Nash	90
18	High-Throughput Phosphotyrosine Profiling Using SH2 Domains 2007 ·Molecular Cell ·Kazuya Machida,Christopher M. Thompson,(unknown),Karl Jablonowski,Satu Kärkkäinen,Bernard A. Liu,Haimin Zhang,Piers Nash,Debra K. Newman,Peter Nollau,Tony Pawson,G. Herma Renkema,Kalle Saksela,Martin R. Schiller,Dong‐Guk Shin,Bruce J. Mayer	140
19	The Human and Mouse Complement of SH2 Domain Proteins—Establishing the Boundaries of Phosphotyrosine Signaling 2006 ·Molecular Cell ·Bernard A. Liu,Karl Jablonowski,(unknown),(unknown),Tony Pawson,Piers Nash	229
20	Inhibitor of DNA Binding/Differentiation Helix-Loop-Helix Proteins Mediate Bone Morphogenetic Protein-induced Osteoblast Differentiation of Mesenchymal Stem Cells 2004 ·Journal of Biological Chemistry ·Ying Peng,Quan Kang,Qing Luo,Wei Jiang,Weike Si,Bernard A. Liu,Hue H. Luu,Jong Kyung Park,Xinmin Li,Jeffrey Luo,Anthony Montag,Rex C. Haydon,Tong‐Chuan He	152

About Bernard A. Liu

Bernard A. Liu is a scholar working on Immunology and Allergy, Radiology, Nuclear Medicine and Imaging and Oncology, having authored 23 papers that have together received 1.3k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (8 papers), Protein Kinase Regulation and GTPase Signaling (7 papers) and Protein Tyrosine Phosphatases (5 papers). The work is most often cited by research in Molecular Biology (1.0k citations), Immunology and Allergy (74 citations) and Radiology, Nuclear Medicine and Imaging (238 citations). Bernard A. Liu has collaborated with scholars based in United States, Canada and Singapore. Frequent co-authors include Piers Nash, Tony Pawson, Karl Jablonowski, Brett W. Engelmann, Michael J. Wagner, Andrew B. Stergachis, Richard B. Jones, Kazuya Machida, Tong‐Chuan He and Weike Si. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact